Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Balchem (BCPC) Change in Accured Expenses (2016 - 2025)

Balchem (BCPC) has disclosed Change in Accured Expenses for 16 consecutive years, with $20.3 million as the latest value for Q4 2025.

  • On a quarterly basis, Change in Accured Expenses rose 8.07% to $20.3 million in Q4 2025 year-over-year; TTM through Dec 2025 was $11.3 million, a 24.57% increase, with the full-year FY2025 number at $11.3 million, up 24.57% from a year prior.
  • Change in Accured Expenses was $20.3 million for Q4 2025 at Balchem, up from -$17.7 million in the prior quarter.
  • In the past five years, Change in Accured Expenses ranged from a high of $22.8 million in Q2 2022 to a low of -$29.9 million in Q4 2022.
  • A 5-year average of $2.8 million and a median of -$528000.0 in 2022 define the central range for Change in Accured Expenses.
  • Peak YoY movement for Change in Accured Expenses: plummeted 575.81% in 2024, then soared 511.13% in 2025.
  • Balchem's Change in Accured Expenses stood at $16.6 million in 2021, then plummeted by 280.13% to -$29.9 million in 2022, then skyrocketed by 133.38% to $10.0 million in 2023, then soared by 88.35% to $18.8 million in 2024, then rose by 8.07% to $20.3 million in 2025.
  • Per Business Quant, the three most recent readings for BCPC's Change in Accured Expenses are $20.3 million (Q4 2025), -$17.7 million (Q3 2025), and $9.4 million (Q2 2025).